| 1 |
Dias E, Farinha I, Costa F. Alpha-1-antitrypsin deficiency (AATD) and spontaneous pneumothorax: Guidelines do not recommend screening for AATD in patients with pneumothorax - What did we find in 10 years of clinical evidence? Pulmonology 2021;27:80-1. [PMID: 32553825 DOI: 10.1016/j.pulmoe.2020.05.014] [Reference Citation Analysis]
|
| 2 |
Sucena M, Gomes J, Guimarães C, Miravitlles M. Implementation of European Alpha-1 Research Collaboration (EARCO) in Portugal: the future starts now. Pulmonology 2020;26:181-3. [DOI: 10.1016/j.pulmoe.2020.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Sousa CS, Teixeira V, Pereira V, Pinheiro RB, Seixas S, Martins N. A rare case of pulmonary disease combining alpha-1-antitrypsin deficiency and common variable immunodeficiency. Pulmonology 2020;26:406-9. [PMID: 32518030 DOI: 10.1016/j.pulmoe.2020.04.016] [Reference Citation Analysis]
|
| 4 |
Seixas S, Marques PI. Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum. Appl Clin Genet 2021;14:173-94. [PMID: 33790624 DOI: 10.2147/TACG.S257511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Santos GF, Ellis P, Farrugia D, Turner AM. Nephrotic syndrome secondary to alpha-1 antitrypsin deficiency. BMJ Case Rep 2021;14:e240288. [PMID: 33674298 DOI: 10.1136/bcr-2020-240288] [Reference Citation Analysis]
|
| 6 |
Cardoso J, Ferreira AJ, Guimarães M, Oliveira AS, Simão P, Sucena M. Treatable Traits in COPD - A Proposed Approach. Int J Chron Obstruct Pulmon Dis 2021;16:3167-82. [PMID: 34824530 DOI: 10.2147/COPD.S330817] [Reference Citation Analysis]
|
| 7 |
Annunziata A, Ferrarotti I, Coppola A, Lanza M, Imitazione P, Spinelli S, Micco PD, Fiorentino G. Alpha-1 Antitrypsin Screening in a Selected Cohort of Patients Affected by Chronic Pulmonary Diseases in Naples, Italy. J Clin Med 2021;10:1546. [PMID: 33916947 DOI: 10.3390/jcm10081546] [Reference Citation Analysis]
|
| 8 |
Jardim JR, Casas-Maldonado F, Fernandes FLA, Castellano MVCO, Torres-Durán M, Miravitlles M. Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil. J Bras Pneumol 2021;47:e20200380. [PMID: 34076174 DOI: 10.36416/1806-3756/e20200380] [Reference Citation Analysis]
|
| 9 |
Greulich T, Albert A, Cassel W, Boeselt T, Peychev E, Klemmer A, Ferreira F, Clarenbach C, Torres-Duran ML, Turner AM, Miravitlles M. Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group. Int J Chron Obstruct Pulmon Dis 2022;17:53-64. [PMID: 35023913 DOI: 10.2147/COPD.S346051] [Reference Citation Analysis]
|
| 10 |
Martín T, Miravitlles M, Furtado ST. A PI*MS is not always a PI*MS. An example of when genotyping for alpha-1 antitrypsin deficiency is necessary. Pulmonology 2021;27:272-3. [PMID: 32723617 DOI: 10.1016/j.pulmoe.2020.06.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
López-Campos JL, Carrasco Hernandez L, Caballero Eraso C. Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy. J Clin Med 2020;9:E2526. [PMID: 32764414 DOI: 10.3390/jcm9082526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Duarte-de-Araújo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: How can evidence from randomised controlled trials apply to patients treated in everyday clinical practice? Pulmonology 2020:S2531-0437(20)30027-1. [PMID: 32169297 DOI: 10.1016/j.pulmoe.2020.02.003] [Reference Citation Analysis]
|
| 13 |
Afonso M, Silva C, Pinho I, Vale A, Fernandes A. A rare mutation on alpha-1 antitrypsin deficit and lung fibrosis: case report. Sarcoidosis Vasc Diffuse Lung Dis 2020;37:e2020019. [PMID: 33597804 DOI: 10.36141/svdld.v37i4.9877] [Reference Citation Analysis]
|
| 14 |
Santos G, Turner AM. Alpha-1 antitrypsin deficiency: an update on clinical aspects of diagnosis and management. Fac Rev 2020;9:1. [PMID: 33659933 DOI: 10.12703/b/9-1] [Reference Citation Analysis]
|
| 15 |
Hernández-Pérez JM, Ramos-Díaz R, Vaquerizo-Pollino C, Pérez JA. Frequency of alleles and genotypes associated with alpha-1 antitrypsin deficiency in clinical and general populations: Revelations about underdiagnosis. Pulmonology 2022:S2531-0437(22)00030-7. [PMID: 35346640 DOI: 10.1016/j.pulmoe.2022.01.017] [Reference Citation Analysis]
|
